Stephanie McDonald, FNP-BC, AOCNP

Nurse Practitioner, Thoracic Oncology Program
Dana-Farber Cancer Institute
Boston, MA

Authored Items

Zongertinib in HER2-Mutant NSCLC With Brain Metastases: Findings From the Beamion LUNG-1 Trial
By Stephanie McDonald, FNP-BC, AOCNP
World Conference on Lung Cancer (WCLC)
WCLC 2025 - Non-Small Cell Lung Cancer
Zongertinib shows promising efficacy in patients with brain metastases in pretreated HER2-mutant non−small cell lung cancer Read More ›
Clinical Outcomes in HER2-Mutant NSCLC Treated With Sevabertinib: Insights From the SOHO-01 Phase 1/2 Trial
By Stephanie McDonald, FNP-BC, AOCNP
World Conference on Lung Cancer (WCLC)
WCLC 2025 - Non-Small Cell Lung Cancer
Sevabertinib demonstrates promising efficacy and manageable safety in pretreated HER2-mutant non−small cell lung cancer (NSCLC) patients Read More ›


© Amplity, Inc. All Rights Reserved. Privacy Policy